2. Academic Validation
  3. Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2

Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2

  • J Med Chem. 2014 Sep 11;57(17):7472-7. doi: 10.1021/jm500857r.
James B Thomas 1,  Angela M Giddings,  Robert W Wiethe,  Srinivas Olepu,  Keith R Warner,  Philippe Sarret,  Louis Gendron,  Jean-Michel Longpre,  Yanan Zhang,  Scott P Runyon,  Brian P Gilmour
Affiliations

Affiliation

  • 1 Center for Organic and Medicinal Chemistry, Research Triangle Institute , P.O. Box 12194, 3040 Cornwallis Road, Research Triangle Park, North Carolina 27709, United States.
PMID: 25157640 DOI: 10.1021/jm500857r
Abstract

Compounds acting via the Neurotensin Receptor type 2 (NTS2) are known to be active in animal models of acute and chronic pain. To identify novel NTS2 selective analgesics, we searched for NTS2 selective nonpeptide compounds using a FLIPR assay and identified the title compound (NTRC-824, 5) that, to our knowledge, is the first nonpeptide that is selective for NTS2 versus NTS1 and behaves like the endogenous ligand neurotensin in the functional assay.

Figures
Products